# 2026-04084: Extra Time to Comment on Drug Plan Fee Disclosures Extended

2026-04084, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period, is a Federal Register proposed rule from Labor Department, Employee Benefits Security Administration published 2026-03-02, effective 2026-01-30; deemed significant under Executive Order 12866 (as of 2026-11-03).

- Canonical: https://policyrisk.com/federal-register/2026-04084
- As of: 2026-11-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04084
- Title: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period
- Type: Proposed Rule
- Agencies: Labor Department; Employee Benefits Security Administration
- Citation: 91 FR 10033
- Published: 2026-03-02
- Effective: 2026-01-30
- Comments close: not stated
- Significant: yes (OIRA_API)
- Touches household money: no
- Regulation identifier numbers: 1210-AB37
- Last updated: 2026-11-03

## In one line

Extra Time to Comment on Drug Plan Fee Disclosures Extended

## Summary

The Department of Labor is giving more time—until April 15, 2026—for people to share their thoughts on a new rule that makes pharmacy benefit managers (the folks who help manage your prescription drug plans) reveal their fees clearly. This rule affects companies handling self-insured group health plans and aims to make sure everyone knows where the money goes. The extra time helps everyone consider recent law changes before final decisions are made.

## Abstract

This document extends the comment period on the Department's Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure proposed rule. The proposed rule would require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA), for purposes of ERISA's statutory prohibited transaction exemption for services arrangements. The proposed rule was published in the Federal Register on January 30, 2026, with a comment deadline of March 31, 2026. On February 3, 2026, the Consolidated Appropriations Act, 2026 amended ERISA to add several provisions relating to providers of pharmacy benefit management services. Consequently, the Department is extending the comment period for an additional 15 days, to April 15, 2026, to allow interested persons to address whether the rule should be adjusted due to these new statutory provisions.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-22306](https://policyrisk.com/federal-register/2026-22306): Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure, 2026-11-02
- [2026-20447](https://policyrisk.com/federal-register/2026-20447): Transparency in Coverage, 2026-10-06
- [2026-17622](https://policyrisk.com/federal-register/2026-17622): Federal Independent Dispute Resolution Operations; Correction, 2026-08-28
- [2026-14917](https://policyrisk.com/federal-register/2026-14917): Electronic Disclosure by Group Health Plans Under ERISA, 2026-07-23
- [2026-11140](https://policyrisk.com/federal-register/2026-11140): Federal Independent Dispute Resolution Operations, 2026-06-04
- [2026-05492](https://policyrisk.com/federal-register/2026-05492): Retirement Security Rule: Definition of an Investment Advice Fiduciary: Notice of Court Vacatur, 2026-03-20

## Sources
- [2026-04084 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/02/2026-04084/improving-transparency-into-pharmacy-benefit-manager-fee-disclosure-extension-of-comment-period)
- [2026-04084 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-02/pdf/2026-04084.pdf)

## Related
- [Previous: 2026-04033, Proposal of Special Measure Regarding MBaer Merchant Bank AG as a Financial Ins…](https://policyrisk.com/federal-register/2026-04033)
- [Next: 2026-04089, Implementing the Guiding and Establishing National Innovation for U.S. Stableco…](https://policyrisk.com/federal-register/2026-04089)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04084 (as of 2026-11-03).